BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 30619775)

  • 1. Serum Levels of Soluble CD40 Ligand and Neopterin in HIV Coinfected Asymptomatic and Symptomatic Visceral Leishmaniasis Patients.
    Adriaensen W; Abdellati S; van Henten S; Gedamu Y; Diro E; Vogt F; Mengesha B; Adem E; Kestens L; van Griensven J
    Front Cell Infect Microbiol; 2018; 8():428. PubMed ID: 30619775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal evaluation of asymptomatic Leishmania infection in HIV-infected individuals in North-West Ethiopia: A pilot study.
    van Griensven J; van Henten S; Mengesha B; Kassa M; Adem E; Endris Seid M; Abdellati S; Asefa W; Simegn T; Debasu D; Bogale T; Gedamu Y; Van Den Bossche D; Adriaensen W; Van der Auwera G; Cnops L; Vogt F; Diro E
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007765. PubMed ID: 31593563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum chemokine profiles in visceral leishmaniasis, HIV and HIV/ visceral leishmaniasis co-infected Ethiopian patients.
    Sisay Z; Berhe N; Petros B; Tegbaru B; Messele T; Hailu A; Wolday D
    Ethiop Med J; 2011 Jul; 49(3):179-86. PubMed ID: 21991751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of serum cytokine levels in symptomatic and asymptomatic HIV-Leishmania coinfected individuals from a Brazilian visceral leishmaniasis endemic area.
    Guedes DL; Silva EDD; Castro MCAB; Júnior WLB; Ibarra-Meneses AV; Tsoumanis A; Adriaensen W; van Griensven J; Pereira VRA; Medeiros ZM
    PLoS Negl Trop Dis; 2022 Jun; 16(6):e0010542. PubMed ID: 35714136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of subclinical Leishmania infection among HIV-infected patients living in the endemic areas of visceral leishmaniasis in Fars province, southern Iran.
    Rezaei Z; Sarkari B; Dehghani M; Layegh Gigloo A; Afrashteh M
    Parasitol Res; 2018 Aug; 117(8):2591-2595. PubMed ID: 29860572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.
    Zijlstra EE
    PLoS Negl Trop Dis; 2014; 8(11):e3258. PubMed ID: 25412435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and determinants of asymptomatic Leishmania infection in HIV-infected individuals living within visceral leishmaniasis endemic areas of Bihar, India.
    Mahajan R; Owen SI; Kumar S; Pandey K; Kazmi S; Kumar V; Adams ER; Harshana A; Burza S
    PLoS Negl Trop Dis; 2022 Aug; 16(8):e0010718. PubMed ID: 36040931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymptomatic Leishmania infection in HIV-positive outpatients on antiretroviral therapy in Pernambuco, Brazil.
    Guedes DL; Justo AM; Barbosa Júnior WL; Silva EDD; Aquino SR; Lima Junior MSDC; Montarroyos U; Bezerra GSN; Vieira AVB; Pereira VRA; Medeiros ZM
    PLoS Negl Trop Dis; 2021 Jan; 15(1):e0009067. PubMed ID: 33476331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble CD40 Ligand in Sera of Subjects Exposed to Leishmania infantum Infection Reduces the Parasite Load in Macrophages.
    de Oliveira FA; Barreto AS; Bomfim LG; Leite TR; Dos Santos PL; de Almeida RP; da Silva ÂM; Duthie MS; Reed SG; de Moura TR; Ribeiro de Jesus A
    PLoS One; 2015; 10(10):e0141265. PubMed ID: 26488744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage Activation Marker Neopterin: A Candidate Biomarker for Treatment Response and Relapse in Visceral Leishmaniasis.
    Kip AE; Wasunna M; Alves F; Schellens JHM; Beijnen JH; Musa AM; Khalil EAG; Dorlo TPC
    Front Cell Infect Microbiol; 2018; 8():181. PubMed ID: 29911074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen Detection in Urine for Noninvasive Diagnosis and Treatment Monitoring of Visceral Leishmaniasis in Human Immunodeficiency Virus Coinfected Patients: An Exploratory Analysis from Ethiopia.
    Vogt F; Mengesha B; Asmamaw H; Mekonnen T; Fikre H; Takele Y; Adem E; Mohammed R; Ritmeijer K; Adriaensen W; Melsew Y; van Griensven J; Diro E
    Am J Trop Med Hyg; 2018 Oct; 99(4):957-966. PubMed ID: 30084342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity and Within-Host Evolution of Leishmania donovani from Visceral Leishmaniasis Patients with and without HIV Coinfection in Northern Ethiopia.
    Franssen SU; Takele Y; Adem E; Sanders MJ; Müller I; Kropf P; Cotton JA
    mBio; 2021 Jun; 12(3):e0097121. PubMed ID: 34182785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre- & post-treatment evaluation of immunological features in Indian visceral leishmaniasis (VL) patients with HIV co-infection.
    Sinha PK; Bimal S; Singh SK; Pandey K; Gangopadhyay DN; Bhattacharya SK
    Indian J Med Res; 2006 Mar; 123(3):197-202. PubMed ID: 16778304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visceral Leishmaniasis-Human Immunodeficiency Virus-Coinfected Patients Are Highly Infectious to Sandflies in an Endemic Area in India.
    Singh OP; Chaubey R; Kushwaha AK; Fay MP; Sacks D; Sundar S
    J Infect Dis; 2024 Jun; 229(6):1909-1912. PubMed ID: 38713583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral Leishmaniasis in Hospitalized HIV-Infected Patients in Pernambuco, Brazil.
    Guedes DL; Medeiros Z; Dionísio da Silva E; Martins de Vasconcelos AV; Santana da Silva M; Lopes da Silva MA; Ramos de Araújo PS; Miranda-Filho DB
    Am J Trop Med Hyg; 2018 Dec; 99(6):1541-1546. PubMed ID: 30328408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 alters T helper cytokines, interleukin-12 and interleukin-18 responses to the protozoan parasite Leishmania donovani.
    Wolday D; Berhe N; Britton S; Akuffo H
    AIDS; 2000 May; 14(8):921-9. PubMed ID: 10853973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood.
    Singh OP; Gidwani K; Kumar R; Nylén S; Jones SL; Boelaert M; Sacks D; Sundar S
    Clin Vaccine Immunol; 2012 Jun; 19(6):961-6. PubMed ID: 22539471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High levels of soluble CD40 ligand and matrix metalloproteinase-9 in serum are associated with favorable clinical evolution in human visceral leishmaniasis.
    de Oliveira FA; Vanessa Oliveira Silva C; Damascena NP; Passos RO; Duthie MS; Guderian JA; Bhatia A; de Moura TR; Reed SG; de Almeida RP; de Jesus AR
    BMC Infect Dis; 2013 Jul; 13():331. PubMed ID: 23870715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New world Leishmania spp. infection in people living with HIV: Concerns about relapses and secondary prophylaxis.
    Araújo CF; Oliveira IBN; Silva MVT; Pereira LIA; Pinto SA; Silveira MB; Dorta ML; Fonseca SG; Gomes RS; Ribeiro-Dias F
    Acta Trop; 2021 Dec; 224():106146. PubMed ID: 34562423
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    van Griensven J; Mengesha B; Mekonnen T; Fikre H; Takele Y; Adem E; Mohammed R; Ritmeijer K; Vogt F; Adriaensen W; Diro E
    Front Cell Infect Microbiol; 2018; 8():94. PubMed ID: 29651411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.